Atherosclerosis drug fails to meet Phase III trial end point.
D050197:Atherosclerosis / Q000188:drug therapy* / Q000201:enzymology; D015415:Biomarkers / Q000097:blood; D017326:Clinical Trials, Phase III as Topic / Q000379:methods / Q000592:standards; D023381:Endpoint Determination / Q000379:methods; D006801:Humans; D007210:Indoleacetic Acids / Q000494:pharmacology / Q000627:therapeutic use*; D002785:Sterol O-Acyltransferase / Q000037:antagonists & inhibitors* / Q000097:blood; D017211:Treatment Failure; D016896:Treatment Outcome
D015415:Biomarkers; D007210:Indoleacetic Acids; C509302:pactimibe; D002785:Sterol O-Acyltransferase